Can we cure asthma? Yes, and we have a plan

Asthma is generally seen as a condition that can be managed but not cured, but recent scientific advances suggest a cure might be possible.
Recent surveys indicate worsening asthma symptoms and attacks, regardless of severity, leading to increased mortality and hospitalizations due to asthma.
Asthma imposes a significant financial burden on Australia’s health system, with around A$1.3 billion spent in 2023–2024, yet outcomes have not improved.
About 20–30% of asthma cases, often in children, experience spontaneous remission, highlighting the potential for a cure.
A cure would involve sustained elimination of symptoms, resolution of underlying disease, and resetting of molecular processes driving asthma.
Potential future medications could correct and reprogram diseased cells, eliminating the need for ongoing medication by targeting “molecular memories” and specific biomarkers.
Research combining molecular level insights, risk factors, and “machine learning” could enable the development of simulated, computer-generated drugs to combat asthma.
Prioritizing research and funding innovations towards an asthma cure represents a significant shift in understanding and achieving this health outcome.